Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Cristina Becchimanzi"'
Publikováno v:
Infectious Agents and Cancer, Vol 19, Iss 1, Pp 1-4 (2024)
Abstract Despite the global vaccination campaigns, certain patient groups remain highly vulnerable to SARS-CoV-2 and are at high risk for unfavorable COVID-19 outcomes. As previously shown by our group and a more recent report by Chang Su and coworke
Externí odkaz:
https://doaj.org/article/8a02b22926f4416e90d81424a8c846d0
Autor:
Gianpaolo Marcacci, Nicola Coppola, Emanuela Madonna, Cristina Becchimanzi, Stefania De Pascalis, Silvia D’Ovidio, Stefania Crisci, Piera Maiolino, Rosaria De Filippi, Antonio Pinto
Publikováno v:
Infectious Agents and Cancer, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Background To date, there is no information on the safety and efficacy of the novel anti-sarbecoviruses monoclonal antibody sotrovimab administered, as a post-exposure prophylactic measure, during the aplastic phase of autologous stem cell t
Externí odkaz:
https://doaj.org/article/cd5de9fa28e448ed9273f321154ab676
Autor:
Annamaria Bonelli, Franco Ionna, Tindaro Gatani, Elisabetta De Lutio, Cristina Becchimanzi, Gaetano Corazzelli, Gianpaolo Marcacci, Antonello Pinto, Rosaria De Filippi, Annarosaria De Chiara, Ferdinando Frigeri, Secondo Lastoria, Gaetana Capobianco, Filippo Russo, Francesco Volzone, Daniela Donnarumma, Luigi Aloj
Publikováno v:
British Journal of Haematology. 166:118-129
Summary We explored activity and safety of a dose-dense/dose-intense adriamycin, bleomycin, vinblastine and dacarbazine regimen (ABVDDD-DI) in 82 patients with advanced Hodgkin Lymphoma. Patients entered a two-stage Bryant-Day Phase II study to recei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b5b6f9402ad058109a6b707d717a227
https://doi.org/10.1111/bjh.12862
https://doi.org/10.1111/bjh.12862
Autor:
Rosaria De Filippi, Mariangela Saggese, Gaetano Corazzelli, Chiara Frairia, Antonio Pinto, Umberto Vitolo, Francesco Volzone, Ferdinando Frigeri, Gennaro Esposito, Manuela Arcamone, Cristina Becchimanzi, Emanuela Morelli, Giampaolo Marcacci, Annarosaria De Chiara, Filippo Russo, Gaetana Capobianco
Publikováno v:
British Journal of Haematology. 156:234-244
Specific trials on adult Burkitt lymphoma (BL) and 'unclassifiable' lymphomas with features intermediate between BL and diffuse large B-cell lymphoma (BL/DLBCL) are advocated which include substantial numbers of older patients, to improve treatment f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56ae8ea57924cb609ec3a05c0b5c9ae6
https://doi.org/10.1111/j.1365-2141.2011.08947.x
https://doi.org/10.1111/j.1365-2141.2011.08947.x
Autor:
Luigi Aloj, Gianpaolo Marcacci, Secondo Lastoria, Antonio Pinto, Rosaria De Filippi, Gaetano Corazzelli, Gaetana Capobianco, Ferdinando Frigeri, Manuela Arcamone, Francesco Volzone, Filippo Russo, Emanuela Morelli, Cristina Becchimanzi
Publikováno v:
European Journal of Haematology. 87:547-553
Non-Hodgkin lymphomas arising from mature post-thymic T cells (T-NHL) encompass biologically heterogeneous malignancies with a dismal prognosis (1, 2). Patients with histotypes such as peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), ki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d4073606465674d06000cf413dc6c57
https://doi.org/10.1111/j.1600-0609.2011.01683.x
https://doi.org/10.1111/j.1600-0609.2011.01683.x
Autor:
Alfonso Amore, Maria RosariaVilla, Rosaria De Filippi, Gaetano Corazzelli, Filippo Russo, Gianpaolo Marcacci, Antonio Pinto, Anna Lucania, Emanuela Morelli, Ferdinando Frigeri, Lucia Mastrullo, Cristina Becchimanzi, Gaetana Capobianco, Manuela Arcamone, Antonietta Caronna, Francesco Volzone
Publikováno v:
British Journal of Haematology
This Phase II study assessed feasibility and efficacy of a biweekly R-COMP-14 regimen (rituximab, cyclophosphamide, non-pegylated liposome-encapsulated doxorubicin, vincristine and prednisone) in untreated elderly patients with poor-risk diffuse larg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e035c38b6501da12b2caee6b9497a8
https://doi.org/10.1111/j.1365-2141.2011.08786.x
https://doi.org/10.1111/j.1365-2141.2011.08786.x
Autor:
Ferdinando Frigeri, Antonio Pinto, Filippo Russo, Pier Ferruccio Ballerini, Gianpaolo Marcacci, Annarosaria De Chiara, Gaetano Corazzelli, Manuela Arcamone, Emilio Iannitto, Gaetana Capobianco, Cristina Becchimanzi
Publikováno v:
Cancer Chemotherapy and Pharmacology. 64:907-916
To determine the efficacy and safety of the combination of gemcitabine plus oxaliplatin, with and without rituximab, in patients with relapsed/refractory B-cell lymphoma unsuitable for high dose therapy.Patients were prospectively enrolled in two sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9c966976b75c32f7d1a3afab6a7dbc5
https://doi.org/10.1007/s00280-009-0941-9
https://doi.org/10.1007/s00280-009-0941-9
Autor:
Fiorella Alfinito, Giuseppe Terrazzano, Bruno Rotoli, Cristina Becchimanzi, Giuseppina Ruggiero, Carmela Cacciapuoti, Michela Sica, Lucia Barone
Publikováno v:
American Journal of Hematology. 82:98-107
Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by the emergence of a GPI-defective clonal hematopoiesis. Its clinical features are hemolytic anemia, cytopenia, and thrombosis. Circulating monocytes and granulocytes are largely GPI-defecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ed6b24d8c66e997cef9f28870b3f639
https://doi.org/10.1002/ajh.20779
https://doi.org/10.1002/ajh.20779
Autor:
Serafino Zappacosta, Michela Sica, Bruno Rotoli, Fiorella Alfinito, Cristina Becchimanzi, Silvia Costantini, Giuseppina Ruggiero, Giuseppe Terrazzano
Publikováno v:
Journal of Leukocyte Biology. 78:27-36
Paroxysmal nocturnal haemoglobin- uria (PNH) is a haematopoieis disorder character- ized by the expansion of a stem cell bearing a somatic mutation in the phosphatidylinositol gly- can-A (PIG-A) gene, which is involved in the bio- synthesis of the gl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65dd4f7bb7240af270c3dd55f9295fd7
https://doi.org/10.1189/jlb.0105026
https://doi.org/10.1189/jlb.0105026
Autor:
Bruno Rotoli, Luigi Racioppi, Serafino Zappacosta, Giuseppe Terrazzano, Claudia Andretta, Cristina Becchimanzi, Fiorella Alfinito, Anna Maria Masci, Michela Sica, Giuseppina Ruggiero
Publikováno v:
Journal of Leukocyte Biology. 76:634-640
Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal, acquired hematopoietic disorder characterized by a phosphatidylinositol (PI) glycan-A gene mutation, which impairs the synthesis of the glycosyl-PI (GPI) anchor, thus causing the absence of all G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e76a61b268925e9b2c712fe106debbc9
https://doi.org/10.1189/jlb.1203607
https://doi.org/10.1189/jlb.1203607